Abstract:Joubert syndrome (JS) is a recessively inherited congenital ataxia characterized by hypotonia, psychomotor delay, abnormal ocular movements, intellectual disability, and a peculiar cerebellar and brainstem malformation, the "molar tooth sign." Over 40 causative genes have been reported, all encoding for proteins implicated in the structure or functioning of the primary cilium, a subcellular organelle widely present in embryonic and adult tissues. In this paper, we developed an in vitro neuronal differentiation model using patient-derived induced pluripotent stem cells (iPSCs), to evaluate possible neurodevelopmental defects in JS. To this end, iPSCs from four JS patients harboring mutations in distinct JS genes ( AHI1, CPLANE1 , TMEM67 , and CC2D2A ) were differentiated alongside healthy control cells to obtain mid-hindbrain precursors and cerebellar granule cells. Differentiation was monitored over 31 days through the detection of lineage-specific marker expression by qRT-PCR, immunofluorescence, and transcriptomics analysis. All JS patient-derived iPSCs, regardless of the mutant gene, showed a similar impairment to differentiate into mid-hindbrain and cerebellar granule cells when compared to healthy controls. In addition, analysis of primary cilium count and morphology showed notable ciliary defects in all differentiating JS patient-derived iPSCs compared to controls. These results confirm that patient-derived iPSCs are an accessible and relevant in vitro model to analyze cellular phenotypes connected to the presence of JS gene mutations in a neuronal context.

What problem does this paper attempt to address?

The problem this paper attempts to address is: using patient-derived induced pluripotent stem cells (iPSCs) to study neurodevelopmental defects associated with Joubert Syndrome (JS). Specifically, the researchers aim to assess the defects in the neurodevelopmental process of iPSCs from JS patients using an in vitro neuronal differentiation model and to investigate the impact of different JS gene mutations on neuronal differentiation. ### Background Information - **Joubert Syndrome (JS)**: A genetic congenital ataxia characterized by hypotonia, psychomotor retardation, abnormal eye movements, intellectual disability, and specific cerebellar and brainstem malformations (known as the "molar tooth sign"). - **Known pathogenic genes**: More than 40 genes are associated with JS, encoding proteins involved in the structure or function of primary cilia. - **Primary cilia**: A subcellular organelle widely present in embryonic and adult tissues, involved in various critical biological processes. ### Research Objectives 1. **Assess the defects in the neurodevelopmental process of iPSCs from JS patients**: By differentiating patient-derived iPSCs into midbrain progenitor cells and cerebellar granule cells, observe whether their differentiation ability is impaired. 2. **Compare the impact of different JS gene mutations on neuronal differentiation**: Analyze the differentiation performance of iPSCs carrying different JS gene mutations. ### Methods - **Generation of iPSCs**: iPSCs were generated from skin fibroblasts of 4 JS patients (carrying mutations in AHI1, CPLANE1, TMEM67, and CC2D2A genes) and 2 healthy controls. - **Differentiation experiments**: iPSCs were differentiated into midbrain progenitor cells and cerebellar granule cells, and the differentiation process was monitored using qRT-PCR, immunofluorescence, and transcriptomic analysis. - **Cilia analysis**: The number and morphology of primary cilia during the differentiation process were detected by immunofluorescence staining. ### Main Findings - **Impaired differentiation ability**: All JS patients' iPSCs showed similar impaired differentiation ability when differentiating into midbrain progenitor cells and cerebellar granule cells, with significantly reduced expression levels compared to the healthy control group. - **Cilia defects**: All JS patients' iPSCs showed a significant reduction in the number and abnormal morphology of primary cilia during the differentiation process. - **Gene expression differences**: Transcriptomic analysis showed that the expression of mature markers was significantly reduced in the differentiation process of JS patients' iPSCs, while early differentiation markers remained dominant. ### Conclusion - **Effectiveness of the iPSCs model**: Patient-derived iPSCs are an accessible and relevant in vitro model for analyzing the cellular phenotype of JS gene mutations in a neuronal context. - **Importance of cilia function**: The role of primary cilia in the neurodevelopmental process is significant, and its dysfunction may lead to specific neurodevelopmental defects in JS patients. Through these studies, researchers hope to provide new insights into the pathogenesis of JS and a theoretical basis for future therapeutic strategies.

Joubert syndrome-derived induced pluripotent stem cells show altered neuronal differentiation in vitro

Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 in Vitro

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Generation of an Induced Pluripotent Stem Cell Line from a Brugada Syndrome Patient Carrying SCN5A/c.3118G>C Mutation

Induced Pluripotent Stem Cells with a Mitochondrial DNA Deletion.

Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

STEM CELLS ® EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Induced Pluripotent Stem Cells with a Pathological Mitochondrial DNA Deletion

Novel CC2D2A compound heterozygous mutations cause Joubert syndrome

Joubert Syndrome and related disorders

AHI1 gene mutations cause specific forms of Joubert syndrome-related disorders

Deregulation of Neuro-Developmental Genes and Primary Cilium Cytoskeleton Anomalies in iPSC Retinal Sheets from Human Syndromic Ciliopathies

Clinical and genetic characteristics of 36 children with Joubert syndrome

Clinical Characteristics and Induced Pluripotent Stem Cells (ipscs) Disease Model of Harel-Yoon Syndrome Caused by Compound Heterozygous ATAD3A Variants

Novel compound heterozygous variants in the CSPP1 gene causes Joubert syndrome: case report and literature review of the CSPP1 gene's pathogenic mechanism

Case report and a brief review: Analysis and challenges of prenatal imaging phenotypes and genotypes in Joubert syndrome

Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses

De novo heterozygous variants in SLC30A7 are a candidate cause for Joubert syndrome

Cerebellar and brainstem development: an overview in relation to Joubert syndrome

Shared and unique consequences of Joubert Syndrome gene dysfunction on the zebrafish central nervous system

A human patient-derived cellular model of Joubert syndrome reveals ciliary defects which can be rescued with targeted therapies

Pathogenic cryptic variants detectable through exome data reanalysis significantly increase the diagnostic yield in Joubert syndrome